SLC5A2 and Hyperglycemia: By reducing plasma glucose levels, glucotoxicity—the toxic effect of hyperglycemia—and insulin resistance and by increasing beta-cell function, SGLT2 inhibitors reverse the previously mentioned intracellular metabolic effects, including oxidative stress, with subsequent renal protection.